drugset / Trial / NCT01189175
Study in Healthy Male Subjects to Investigate Whether Ketoconazole Affects Plasma Exposure of BI 113823
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The objective of the study is to investigate whether ketoconazole affects plasma exposure of BI 113823
Timeline
- Start
- 2010-08
- Primary completion
- 2010-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 113823 | Unknown | 50 mg | Oral |
| Subject | Ketoconazole | Small molecule | 200 mg | Oral |
Indications
No indication recorded.